联合性毛细血管后和毛细血管前肺动脉高压的临床与生物学见解
研究利用范德堡大学电子病历与DNA生物样本库,纳入1998至2014年接受右心导管检查的2817例肺动脉高压患者,比较孤立性毛细血管后肺动脉高压(Ipc-PH)与联合性毛细血管后和毛细血管前肺动脉高压(Cpc-PH)的临床和遗传特征。结果显示Cpc-PH患者更年轻、肺血管病变更严重,但校正协变量后两组死亡风险相似(HR 1.14,95%CI 0.96-1.35,P=0.15),且Cpc-PH与肺动脉高压(PAH)共享75个外显子单核苷酸多态性,富集于细胞结构、细胞外基质和免疫相关通路。
要点
- Cpc-PH患者平均比Ipc-PH年轻6岁,肺血管病变更严重,但左心疾病患病率与严重程度相似。
- 校正协变量后,Cpc-PH与Ipc-PH的死亡风险相似(HR 1.14,95%CI 0.96-1.35,P=0.15)。
- Cpc-PH与PAH共享75个外显子单核苷酸多态性,相关基因在肺组织表达平均高32%。
核心结论
- Cpc-PH患者尽管较Ipc-PH年轻且肥胖、糖尿病和左心疾病患病率相似,但肺血管病变与PAH患者相似。
- 探索性遗传分析发现Cpc-PH中与PAH病理生理相关的肺基因和生物学通路,提示Cpc-PH可能是独特且高致病性的PH亚型。
研究设计与样本
- 利用范德堡大学电子病历与DNA生物样本库,提取1998至2014年间所有转诊接受右心导管检查患者的人口学、临床、侵入性血流动力学、超声心动图和生命状态数据。
- 共识别2817例PH患者,其中13%为Cpc-PH,52%为Ipc-PH,20%为PAH。
- 使用预先存在的单核苷酸多态性数据识别PAH与Cpc-PH相较于Ipc-PH共享的遗传变异。
主要发现
- Cpc-PH患者平均比Ipc-PH患者年轻6岁,肺血管疾病更严重,但合并症及左心疾病的患病率、严重程度和慢性程度相似。
- 校正相关协变量后,按舒张压梯度定义时,Cpc-PH与Ipc-PH组的死亡风险相似(HR 1.14,95%CI 0.96-1.35,P=0.15)。
- 识别出Cpc-PH与PAH之间75个共享外显子单核苷酸多态性,富集于涉及细胞结构、细胞外基质和免疫功能的通路,这些基因在肺组织中的表达平均比其他组织高32%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pulmonary hypertension (PH) is a common and morbid complication of left heart disease with 2 subtypes: isolated post-capillary pulmonary hypertension (Ipc-PH) and combined post-capillary and pre-capillary pulmonary hypertension (Cpc-PH). Little is known about the clinical or physiological characteristics that distinguish these 2 subphenotypes or if Cpc-PH shares molecular similarities to pulmonary arterial hypertension (PAH). OBJECTIVES: The goal of this study was to test the hypothesis that the hemodynamic and genetic profile of Cpc-PH would more closely resemble PAH than Ipc-PH. METHODS: Vanderbilt University's electronic medical record linked to a DNA biorepository was used to extract demographic characteristics, clinical data, invasive hemodynamic data, echocardiography, and vital status for all patients referred for right heart catheterization between 1998 and 2014. Shared genetic variants between PAH and Cpc-PH compared with Ipc-PH were identified by using pre-existing single-nucleotide polymorphism data. RESULTS: A total of 2,817 patients with PH (13% Cpc-PH, 52% Ipc-PH, and 20% PAH) were identified. Patients with Cpc-PH were on average 6 years younger, with more severe pulmonary vascular disease than patients with Ipc-PH, despite similar comorbidities and prevalence, severity, and chronicity of left heart disease. After adjusting for relevant covariates, the risk of death was similar between the Cpc-PH and Ipc-PH groups (hazard ratio: 1.14; 95% confidence interval: 0.96 to 1.35; p = 0.15) when defined according to diastolic pressure gradient. We identified 75 shared exonic single-nucleotide polymorphisms between Cpc-PH and PAH enriched in pathways involving cell structure, extracellular matrix, and immune function. These genes are expressed, on average, 32% higher in lungs relative to other tissues. CONCLUSIONS: Patients with Cpc-PH develop pulmonary vascular disease similar to patients with PAH, despite younger age and similar prevalence of obesity, diabetes mellitus, and left heart disease compared with patients with Ipc-PH. An exploratory genetic analysis in Cpc-PH identified genes and biological pathways in the lung known to contribute to PAH pathophysiology, suggesting that Cpc-PH may be a distinct and highly morbid PH subphenotype.
引用
- Assad TR, Hemnes AR, Larkin EK, et al. Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension. J Am Coll Cardiol. 2016. PMID: 27931609. doi:10.1016/j.jacc.2016.09.942
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。